Skip to main content

Mark Cuban's cost plus drug company sparks moves to change how Rx drugs are priced

By Forbes  
   January 02, 2024

Two years in, Mark Cuban's company keeps shaking up the generic pharmaceutical space.

Full story


Get the latest on healthcare leadership in your inbox.